Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05815186
Title Ladarixin With Sotorasib in Advanced NSCLC - Phase II
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors NYU Langone Health
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
NYU Langone Health Garden City New York 11530 United States Details
NYU Langone Health Mineola New York 11501 United States Details
NYU Langone Health New Hyde Park New York 11042 United States Details
NYU Langone Health New York New York 10010 United States Details
NYU Langone Health New York New York 10016 United States Details
NYU Langone Health New York New York 10017 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field